Hepion Pharmaceuticals raises authorized common shares to 750,000,000
HEPA•Hepion Pharmaceuticals raised its authorized common shares to 750,000,000 in an amendment filed Oct. 1, 2026, which took effect upon filing in Delaware.
1. Share authorization amended
Hepion Pharmaceuticals filed a certificate of amendment to its certificate of incorporation on Oct. 1, 2026, raising its authorized common shares to 750,000,000. The amendment took effect upon filing in Delaware.
